Harpoon Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Harpoon Therapeutics

10/11/2021 23:09

* Harpoon Therapeutics Inc  HARP.OQ  reported a quarterly
adjusted loss of 51 cents​​ per share for the quarter ended in
September. The mean expectation of ten analysts for the quarter
was for a loss of 52 cents per share.
* Revenue rose 15.2% to $4.48 million from a year ago;  analysts
expected $6.30 million. 
* Harpoon Therapeutics Inc's reported EPS for the quarter was a
loss of 51 cents​.
* The mean earnings estimate of analysts had fallen by
about 1.2% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Harpoon Therapeutics Inc shares had fallen by 15.7% this
quarter and lost 59.9% so far this year.
* The company reported a quarterly loss of $16.68 million.
* Wall Street's median 12-month price target for Harpoon
Therapeutics Inc is $30.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 10 at 11:09 p.m.
 ​All figures in US dollars unless otherwise stated